SE7503542L - - Google Patents
Info
- Publication number
- SE7503542L SE7503542L SE7503542A SE7503542A SE7503542L SE 7503542 L SE7503542 L SE 7503542L SE 7503542 A SE7503542 A SE 7503542A SE 7503542 A SE7503542 A SE 7503542A SE 7503542 L SE7503542 L SE 7503542L
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- parenteral administration
- diisopropylphenol
- warm
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1373974A GB1472793A (en) | 1974-03-28 | 1974-03-28 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SE7503542L true SE7503542L (de) | 1975-09-29 |
Family
ID=10028495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7503542A SE7503542L (de) | 1974-03-28 | 1975-03-26 |
Country Status (22)
Country | Link |
---|---|
US (2) | US4056635A (de) |
JP (1) | JPS50154410A (de) |
AU (1) | AU502164B2 (de) |
BE (1) | BE827290A (de) |
CA (1) | CA1038764A (de) |
DE (1) | DE2513797C2 (de) |
DK (1) | DK128675A (de) |
DO (1) | DOP1980002892A (de) |
FI (1) | FI750941A (de) |
FR (1) | FR2265357B1 (de) |
GB (1) | GB1472793A (de) |
HK (1) | HK34380A (de) |
IE (1) | IE40839B1 (de) |
IL (1) | IL46899A (de) |
KE (1) | KE3052A (de) |
MY (1) | MY8100111A (de) |
NL (2) | NL183079C (de) |
NO (1) | NO751076L (de) |
NZ (1) | NZ177023A (de) |
PH (1) | PH13553A (de) |
SE (1) | SE7503542L (de) |
ZA (1) | ZA751806B (de) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU223343B1 (hu) * | 1991-05-20 | 2004-06-28 | Novartis Ag. | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására |
US6005001A (en) * | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US20020173547A1 (en) | 1994-03-22 | 2002-11-21 | Jones Christopher Buchan | Pharmaceuticals compositions |
US5731356A (en) * | 1994-03-22 | 1998-03-24 | Zeneca Limited | Pharmaceutical compositions of propofol and edetate |
MY113046A (en) * | 1994-03-22 | 2001-11-30 | Astrazeneca Uk Ltd | Pharmaceutical compositions |
GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
IT1269977B (it) | 1994-07-01 | 1997-04-16 | Archimica Spa | Purificazione del propofol |
IT1270093B (it) | 1994-09-28 | 1997-04-28 | Zambon Spa | Processo per la purificazione di 2,6-diisopropilfenolo |
CN100457086C (zh) * | 1995-03-17 | 2009-02-04 | 曾尼卡有限公司 | 无菌医药组合物 |
CN1106192C (zh) * | 1995-03-17 | 2003-04-23 | 曾尼卡有限公司 | 含2,6-二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液 |
AU6708096A (en) * | 1995-09-18 | 1997-04-09 | Vesifact Ag | Propofol nanodispersions |
CA2234957C (en) | 1995-10-17 | 2006-12-19 | Inge B. Henriksen | Insoluble drug delivery |
US5637625A (en) * | 1996-03-19 | 1997-06-10 | Research Triangle Pharmaceuticals Ltd. | Propofol microdroplet formulations |
US6465016B2 (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
DE19709704C2 (de) * | 1997-03-10 | 1999-11-04 | Michael Georgieff | Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie |
CH692322A5 (it) | 1997-05-26 | 2002-05-15 | Westy Ag | Formulazione iniettabile limpida di Propofol. |
US8853260B2 (en) * | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
DE19757224A1 (de) | 1997-12-22 | 1999-07-01 | Bayer Ag | Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation |
CA2319810C (en) * | 1998-02-10 | 2008-12-23 | Gensia Sicor Inc. | Propofol composition containing sulfite |
IL137734A0 (en) * | 1998-02-11 | 2001-10-31 | Res Triangle Pharm Ltd | Method and composition for treatment of inflammatory conditions |
US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
AU764001B2 (en) | 1998-05-29 | 2003-08-07 | Skyepharma Canada Inc. | Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
JP4198318B2 (ja) | 1998-08-19 | 2008-12-17 | ヤーゴテック アクチェンゲゼルシャフト | プロポフォールの注射可能水性分散物 |
US6150423A (en) * | 1998-10-15 | 2000-11-21 | Phoenix Scientific, Inc. | Propofol-based anesthetic and method of making same |
US6028108A (en) * | 1998-10-22 | 2000-02-22 | America Home Products Corporation | Propofol composition comprising pentetate |
US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
CA2349203C (en) | 1998-11-20 | 2013-05-21 | Rtp Pharma Inc. | Dispersible phospholipid stabilized microparticles |
US6177477B1 (en) * | 1999-03-24 | 2001-01-23 | American Home Products Corporation | Propofol formulation containing TRIS |
US6100302A (en) | 1999-04-05 | 2000-08-08 | Baxter International Inc. | Propofol formulation with enhanced microbial characteristics |
ES2261210T3 (es) * | 1999-06-21 | 2006-11-16 | Kuhnil Pharmaceutical Co., Ltd. | Comoposicion anestesica para inyeccion intravenosa que comprende propofol. |
GB2359747B (en) * | 2000-02-29 | 2002-04-24 | Maelor Pharmaceuticals Ltd | Anaesthetic formulations |
KR100386397B1 (ko) * | 2000-04-19 | 2003-06-02 | 센츄론(주) | 투명한 프로포폴 주사제 |
EP1276465B1 (de) | 2000-04-20 | 2014-03-12 | Jagotec AG | Verbessertes verfahren zur herstellung wasserunlöslicher arzneistoffpartikel |
US6726919B2 (en) | 2000-06-16 | 2004-04-27 | Rtp Pharma, Inc. | Injectable dispersion of propofol |
DE10041479A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 |
DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
ATE424811T1 (de) | 2000-08-31 | 2009-03-15 | Jagotec Ag | Gemahlene partikel |
US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
US6977085B2 (en) * | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
US6951656B2 (en) * | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US8067032B2 (en) * | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
US7037528B2 (en) * | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US7193084B2 (en) * | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US20040022862A1 (en) * | 2000-12-22 | 2004-02-05 | Kipp James E. | Method for preparing small particles |
US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US20030096013A1 (en) * | 2000-12-22 | 2003-05-22 | Jane Werling | Preparation of submicron sized particles with polymorph control |
US20030072807A1 (en) * | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
JP2004523552A (ja) * | 2001-02-22 | 2004-08-05 | スカイファーマ・カナダ・インコーポレーテッド | 低減した摂食−絶食効果を伴うフィブラート−スタチンの組合わせ |
JP4127757B2 (ja) * | 2001-08-21 | 2008-07-30 | 株式会社エヌ・ティ・ティ・ドコモ | 無線通信システム、通信端末装置、及びバースト信号送信方法 |
GB0120702D0 (en) * | 2001-08-24 | 2001-10-17 | Maelor Pharmaceuticals Ltd | Anaesthetic formulations |
JP2005504090A (ja) | 2001-09-26 | 2005-02-10 | バクスター・インターナショナル・インコーポレイテッド | 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製 |
US6815555B2 (en) | 2001-09-26 | 2004-11-09 | Theravance, Inc. | Substituted phenol compounds useful for anesthesia and sedation |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
JP3931680B2 (ja) * | 2002-02-18 | 2007-06-20 | 株式会社日本自動車部品総合研究所 | 車両の直進判別装置 |
US20040220283A1 (en) * | 2002-07-29 | 2004-11-04 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
EP1539122B1 (de) * | 2002-07-29 | 2014-01-29 | Transform Pharmaceuticals, Inc. | Pharmazeutische wässrige 2,6-diisopropylphenol-zusammensetzungen |
US7550155B2 (en) * | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
WO2004039360A1 (en) * | 2002-10-29 | 2004-05-13 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
CN1708270A (zh) * | 2002-10-29 | 2005-12-14 | 转化医药公司 | 丙泊酚与半胱氨酸 |
PT1566378E (pt) | 2002-11-26 | 2012-11-29 | Maruishi Pharma | Derivado de isoindolina |
US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
US8476010B2 (en) | 2003-07-10 | 2013-07-02 | App Pharmaceuticals Llc | Propofol formulations with non-reactive container closures |
US8546453B2 (en) * | 2003-08-14 | 2013-10-01 | Rensheng Zhang | Propofol compositions and methods for reducing pain associated with propofol injection |
ITMI20032054A1 (it) * | 2003-10-22 | 2005-04-23 | Monteres S R L | Processo per la preparazione di sospensioni farmaceutiche da inalare. |
EP1706128B1 (de) | 2003-12-08 | 2010-07-21 | CPEX Pharmaceuticals, Inc. | Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung |
EP1711163A2 (de) * | 2004-02-05 | 2006-10-18 | Baxter International Inc. | Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen |
US20060280787A1 (en) * | 2005-06-14 | 2006-12-14 | Baxter International Inc. | Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof |
MX2007015183A (es) * | 2005-06-14 | 2008-02-19 | Baxter Int | Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco. |
US20100048732A1 (en) * | 2006-05-30 | 2010-02-25 | Emala Sr Charles W | Method of mediating Airway Smooth Muscle Construction Due to Airway Irritation |
US7705191B2 (en) * | 2006-07-13 | 2010-04-27 | University Of Iowa Research Foundation | Hydrofluoroalkyl phenols having anesthetic properties |
WO2008080047A2 (en) * | 2006-12-23 | 2008-07-03 | Baxter International Inc. | Magnetic separation of fine particles from compositions |
RU2470908C2 (ru) * | 2007-05-09 | 2012-12-27 | Сигничер Терапьютикс, Инк. | Терапевтические соединения |
BRPI0811284A2 (pt) | 2007-05-09 | 2015-01-20 | Pharmacofore Inc | Compostos terapêuticos |
US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
US20090198145A1 (en) * | 2008-02-06 | 2009-08-06 | Chow Harrison | Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep |
WO2016061538A1 (en) | 2014-10-16 | 2016-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Novel methods, compounds, and compositions for anesthesia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2104412A (en) * | 1931-12-29 | 1938-01-04 | Standard Oil Dev Co | Alkyl phenols |
GB831071A (en) | 1956-04-26 | 1960-03-23 | British Schering Ltd | Analgesic compounds |
GB803080A (en) | 1956-07-06 | 1958-10-15 | Scient Oil Compounding Co Inc | Bacteriostatic compositions |
US2966442A (en) * | 1956-09-20 | 1960-12-27 | American Home Prod | Antibiotic compositions |
US3476838A (en) * | 1958-12-04 | 1969-11-04 | Ethyl Corp | Di(2,6-diisopropylphenyl) mono halo phosphite or (thio) phosphate |
US3067106A (en) * | 1959-04-07 | 1962-12-04 | Foundation For Prosthetic Res | Skin treating method and composition |
-
1974
- 1974-03-28 GB GB1373974A patent/GB1472793A/en not_active Expired
-
1975
- 1975-03-18 IE IE587/75A patent/IE40839B1/xx not_active IP Right Cessation
- 1975-03-19 US US05/559,880 patent/US4056635A/en not_active Expired - Lifetime
- 1975-03-21 CA CA222,804A patent/CA1038764A/en not_active Expired
- 1975-03-21 ZA ZA00751806A patent/ZA751806B/xx unknown
- 1975-03-24 NZ NZ177023A patent/NZ177023A/xx unknown
- 1975-03-24 IL IL46899A patent/IL46899A/xx unknown
- 1975-03-25 DK DK128675A patent/DK128675A/de not_active Application Discontinuation
- 1975-03-26 PH PH16980A patent/PH13553A/en unknown
- 1975-03-26 NO NO751076A patent/NO751076L/no unknown
- 1975-03-26 SE SE7503542A patent/SE7503542L/ unknown
- 1975-03-26 AU AU79536/75A patent/AU502164B2/en not_active Ceased
- 1975-03-27 BE BE154864A patent/BE827290A/xx not_active IP Right Cessation
- 1975-03-27 FR FR7509683A patent/FR2265357B1/fr not_active Expired
- 1975-03-27 DE DE2513797A patent/DE2513797C2/de not_active Expired
- 1975-03-27 NL NLAANVRAGE7503696,A patent/NL183079C/xx active Protection Beyond IP Right Term
- 1975-03-27 FI FI750941A patent/FI750941A/fi not_active Application Discontinuation
- 1975-03-28 JP JP50037699A patent/JPS50154410A/ja active Pending
-
1977
- 1977-09-19 US US05/834,292 patent/US4452817A/en not_active Expired - Lifetime
-
1980
- 1980-06-05 KE KE3052A patent/KE3052A/xx unknown
- 1980-06-26 HK HK343/80A patent/HK34380A/xx unknown
- 1980-08-01 DO DO1980002892A patent/DOP1980002892A/es unknown
-
1981
- 1981-12-30 MY MY111/81A patent/MY8100111A/xx unknown
-
1993
- 1993-06-22 NL NL930084C patent/NL930084I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
AU7953675A (en) | 1976-09-30 |
IL46899A0 (en) | 1975-06-25 |
KE3052A (en) | 1980-06-27 |
GB1472793A (en) | 1977-05-04 |
FI750941A (de) | 1975-09-29 |
US4452817A (en) | 1984-06-05 |
IL46899A (en) | 1978-03-10 |
US4056635A (en) | 1977-11-01 |
FR2265357A1 (fr) | 1975-10-24 |
NL183079C (nl) | 1988-07-18 |
NL930084I1 (nl) | 1993-09-16 |
CA1038764A (en) | 1978-09-19 |
NZ177023A (en) | 1984-09-28 |
FR2265357B1 (fr) | 1978-08-04 |
IE40839B1 (en) | 1979-08-29 |
NL930084I2 (nl) | 1994-10-17 |
DE2513797C2 (de) | 1987-07-30 |
ZA751806B (en) | 1976-02-25 |
IE40839L (en) | 1975-09-28 |
BE827290A (fr) | 1975-09-29 |
MY8100111A (de) | 1981-12-31 |
DK128675A (de) | 1975-09-29 |
DOP1980002892A (es) | 1989-10-04 |
NO751076L (de) | 1975-09-30 |
AU502164B2 (en) | 1979-07-12 |
DE2513797A1 (de) | 1975-10-09 |
HK34380A (en) | 1980-07-01 |
JPS50154410A (de) | 1975-12-12 |
PH13553A (en) | 1980-06-26 |
NL7503696A (nl) | 1975-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7503542L (de) | ||
SE7613959L (sv) | Antibiotisk komposition och forfarande for framstellning derav | |
HUT44441A (en) | Process for preparing antineoplastic pharmaceutical composition | |
EP0014958B1 (en) | Process for the preparation of 4,5-perfluoro-1,3-dioxolanes | |
DE2966179D1 (en) | Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same | |
JPS51139617A (en) | A process for preparing a remedy for intestinal infectious diseases | |
ES458967A1 (es) | Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada. | |
PH24207A (en) | 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles | |
DE3161204D1 (en) | 2-alkyl-5-hydroxy-1,4-naphthoquinones, process for their manufacture and pharmaceutical preparations containing these compounds | |
SE8305386D0 (sv) | 15-cycloaliphatic derivatives of 13,14-didehydro-carboprostacyclins and process for their preparation | |
SE7507667L (sv) | Sett att framstella 2-substituerade 5-oxo-5h-dibenso (a,d)-cukloheptener och anvendning derav som lekemedel | |
DE3476398D1 (en) | An anthracycline compound, a process for the production thereof, a pharmaceutical composition containing the same and its use as a medicament | |
IE42100L (en) | Process for the preparation of 2, 2, 2-trichloroethyl¹chloroformate | |
SE7509607L (sv) | Forfarnde for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat | |
AU490537B2 (en) | A process for preparing 1, 3 thiazane and 1, 3 thiazine derivatives, andthe compounds so produced | |
SE7502232L (sv) | Sett att framstella 3-oxo-17beta-n-amyloxi-estra-4,9,11-trien | |
CA953741A (en) | Process for producing bicyclo-(3,3,0)-octene-(2) | |
CA919700A (en) | (3,4,5-trialkoxybenzoyl) aminoalkanoic acids, salts thereof and process for producing same | |
IL36584A0 (en) | Bis(4-substituted-3,5-dinitrophenyl)disulfide compounds and process for preparing same | |
BE830576A (fr) | Derives actifs d'acetoxime, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions | |
AU485558B2 (en) | N, n'disubstituted naphthaleneacetamidines | |
GB1475651A (en) | Pharmaceutical composition for the treatment of cancer | |
JPS5241242A (en) | Method of killing tape worm imagoes | |
YU36609B (en) | Process for obtaining 3,6,9-trioxa-undecane-1,1-dioyl-bis-(3-carboxy-2,4,6-triiodo-analides) and salts thereof with physiologically tolerated bases | |
CH532551A (fr) | Procédé de préparation de dérivés d'a,a,a,a',a',a'-hexafluoro-di-tolylamine |